Dynavax Technologies Corporation
DVAX
$10.97
$0.090.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 317.84M | 307.23M | 285.55M | 268.43M | 248.46M |
| Total Other Revenue | 12.68M | 9.04M | 9.08M | 8.82M | 12.35M |
| Total Revenue | 330.51M | 316.27M | 294.62M | 277.25M | 260.81M |
| Cost of Revenue | 113.67M | 107.60M | 105.60M | 96.85M | 87.47M |
| Gross Profit | 216.85M | 208.67M | 189.02M | 180.40M | 173.34M |
| SG&A Expenses | 184.28M | 187.30M | 178.75M | 168.10M | 168.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 311.19M | 308.16M | 295.76M | 276.35M | 266.99M |
| Operating Income | 19.32M | 8.11M | -1.14M | 893.00K | -6.18M |
| Income Before Tax | -40.61M | -49.21M | -55.52M | 30.86M | 24.22M |
| Income Tax Expenses | 2.79M | 3.52M | 4.55M | 3.55M | 3.75M |
| Earnings from Continuing Operations | -43.40 | -52.73 | -60.07 | 27.31 | 20.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.40M | -52.73M | -60.07M | 27.31M | 20.48M |
| EBIT | 19.32M | 8.11M | -1.14M | 893.00K | -6.18M |
| EBITDA | 24.21M | 12.90M | 3.54M | 5.52M | -1.62M |
| EPS Basic | -0.33 | -0.42 | -0.49 | 0.21 | 0.16 |
| Normalized Basic EPS | 0.22 | 0.16 | 0.12 | 0.15 | 0.12 |
| EPS Diluted | -0.38 | -0.46 | -0.52 | 0.18 | 0.13 |
| Normalized Diluted EPS | 0.18 | 0.13 | 0.09 | 0.12 | 0.09 |
| Average Basic Shares Outstanding | 489.45M | 503.27M | 514.87M | 520.20M | 521.63M |
| Average Diluted Shares Outstanding | 552.72M | 571.06M | 587.17M | 592.50M | 572.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |